ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon Print

Landmark surgery a step forward for iPS, says Nobel laureate

Shinya Yamanaka says breakthrough will reduce costs, time for transplants

Shinya Yamanaka hopes a recent transplant involving donor-derived iPS cells will lead to the widespread use of regenerative treatments.

KYOTO -- A team of Japanese doctors last week performed landmark surgery that transplanted stocked, donated induced pluripotent stem, or iPS cells, into a patient with an intractable eye disease.

If successful, the surgery at Kobe City Medical Center General Hospital, performed under a joint project also involving researchers from Riken and Kyoto University's Center for iPS Cell Research and Application, or CiRA, will pave the way for wider use of regenerative treatment.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more